These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9647670)

  • 41. Accumulation of prenyl alcohols by terpenoid biosynthesis inhibitors in various microorganisms.
    Muramatsu M; Ohto C; Obata S; Sakuradani E; Shimizu S
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):589-95. PubMed ID: 18636253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis.
    Jones CA; Sidebottom PJ; Cannell RJ; Noble D; Rudd BA
    J Antibiot (Tokyo); 1992 Sep; 45(9):1492-8. PubMed ID: 1429235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
    Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
    J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ergosterol biosynthesis inhibitor zaragozic acid promotes vacuolar degradation of the tryptophan permease Tat2p in yeast.
    Daicho K; Maruyama H; Suzuki A; Ueno M; Uritani M; Ushimaru T
    Biochim Biophys Acta; 2007 Jul; 1768(7):1681-90. PubMed ID: 17531951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Link between cholesterol levels and phenobarbital induction of cytochromes P450.
    Ourlin JC; Handschin C; Kaufmann M; Meyer UA
    Biochem Biophys Res Commun; 2002 Feb; 291(2):378-84. PubMed ID: 11846416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gas chromatography-mass spectrometric method for quantitative determination in human urine of dicarboxylic (dioic) acids produced in the body as a consequence of cholesterol biosynthesis inhibition.
    Jemal M; Ouyang Z
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):233-41. PubMed ID: 9657220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Competitive inhibition of squalene synthetase by squalestatin 1.
    Hasumi K; Tachikawa K; Sakai K; Murakawa S; Yoshikawa N; Kumazawa S; Endo A
    J Antibiot (Tokyo); 1993 Apr; 46(4):689-91. PubMed ID: 8501015
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
    Fulton DC; Tait M; Threlfall DR
    Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation.
    Lindsey S; Harwood HJ
    J Biol Chem; 1995 Apr; 270(16):9083-96. PubMed ID: 7721822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of additional squalestatin analogues by directed biosynthesis.
    Cannell RJ; Dawson MJ; Hale RS; Hall RM; Noble D; Lynn S; Taylor NL
    J Antibiot (Tokyo); 1994 Feb; 47(2):247-9. PubMed ID: 8150722
    [No Abstract]   [Full Text] [Related]  

  • 52. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
    Brusselmans K; Timmermans L; Van de Sande T; Van Veldhoven PP; Guan G; Shechter I; Claessens F; Verhoeven G; Swinnen JV
    J Biol Chem; 2007 Jun; 282(26):18777-85. PubMed ID: 17483544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
    Baxter A; Fitzgerald BJ; Hutson JL; McCarthy AD; Motteram JM; Ross BC; Sapra M; Snowden MA; Watson NS; Williams RJ
    J Biol Chem; 1992 Jun; 267(17):11705-8. PubMed ID: 1601846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of fatty acid synthase expression by cholesterol in human cultured cells.
    Kawabe Y; Sato R; Matsumoto A; Honda M; Wada Y; Yazaki Y; Endo A; Takano T; Itakura H; Kodama T
    Biochem Biophys Res Commun; 1996 Feb; 219(2):515-20. PubMed ID: 8605019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.
    Shidoji Y; Tabata Y
    J Lipid Res; 2019 Mar; 60(3):579-593. PubMed ID: 30622150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel squalestatins produced by biotransformation.
    Middleton RF; Foster G; Cannell RJ; Sidebottom PJ; Taylor NL; Noble D; Todd M; Dawson MJ; Lawrence GC
    J Antibiot (Tokyo); 1995 Apr; 48(4):311-6. PubMed ID: 7775268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes.
    Hiyoshi H; Yanagimachi M; Ito M; Yasuda N; Okada T; Ikuta H; Shinmyo D; Tanaka K; Kurusu N; Yoshida I; Abe S; Saeki T; Tanaka H
    J Lipid Res; 2003 Jan; 44(1):128-35. PubMed ID: 12518031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in cell cholesterol content modulate Ca(2+)-induced tight junction assembly by MDCK cells.
    Stankewich MC; Francis SA; Vu QU; Schneeberger EE; Lynch RD
    Lipids; 1996 Aug; 31(8):817-28. PubMed ID: 8869884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase.
    Liu CI; Jeng WY; Chang WJ; Ko TP; Wang AH
    J Biol Chem; 2012 May; 287(22):18750-7. PubMed ID: 22474324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration.
    Pastar I; Stojadinovic O; Sawaya AP; Stone RC; Lindley LE; Ojeh N; Vukelic S; Samuels HH; Tomic-Canic M
    J Cell Physiol; 2016 Nov; 231(11):2452-63. PubMed ID: 26916741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.